The Latest Podcasts
An Inside Look at the FDA and Early Drug Development
June 18, 2024
Featuring: Dr. Amanda Holley
In this episode, Joe interviews Dr. Amanda Holley: pharmacologist and regulatory consultant in nonclinical drug development, and previously a nonclinical pharmacology/toxicology reviewer at the FDA. With Lykos Therapeutics working towards…
Subscribe
Community, Group Process, and Co-Creation: How to Build a Successful Retreat
In this episode of Vital Psychedelic Conversations, Kyle interviews two Vital graduates: Alice Dommert: certified…
Featured Guest: Alice Dommert & Kara Tremain, ACC
From the Eleusinian Mysteries to Modern Mysticism: The Role of Religion in the Psychedelic Experience
In this episode, Joe interviews Charles Stang: Professor of Early Christian Thought and the Director…
Featured Guest: Charles Stang
Filter
Exploring Somatic Practices and Psychedelics
In this episode – the first in the 2024 series of Vital Psychedelic Conversations –…
Featured Guest: Pierre Bouchard, LPC & Kara Tremain, ACC
The EMBARK Model of Psychedelic Therapy
In this episode, Kyle interviews Alex Belser, Ph.D. and Bill Brennan, Ph.D.: psychologists, psychedelic researchers,…
Featured Guest: Alex Belser, Ph.D. & Bill Brennan, Ph.D.
Long COVID and Psychedelics
In this episode, special guest host Court Wing interviews Monica Verduzco-Gutierrez, MD: professor and chair…
Featured Guest: Monica Verduzco-Gutierrez, MD, Joel Castellanos, MD, & MaryAnn Welke Lesage
Embracing the Mystery: Making Psychedelic Literature Engaging
In this episode, Joe interviews Sean Lawlor: writer and therapist specializing in ketamine-assisted therapy at…
Featured Guest: Sean Lawlor
The Economics of Psychedelics
In this episode, Joe interviews Elliot Marseille, DrPH, MPP: founding director of UC Berkeley’s Collaborative…
Featured Guest: Elliot Marseille, DrPH, MPP
Breaking Through Bureaucracy: Can D.C. Embrace Evidence-Based Drug Policy?
In this episode, Joe interviews two members of The Daschle Group: Founder and CEO, Senator…